Research on the Epidemiology, Prevention, Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa
The NCIRD Influenza Division (ID) is seeking to initiate a cooperative agreement with the National Institute for Communicable Diseases (NICD), Republic of South Africa, to conduct research studies on the epidemiology, disease burden, transmission, risk factors for hospitalization, and effectiveness of
vaccination and antiviral treatment for influenza and other respiratory diseases of public health importance.
South Africa’s Viral Watch Programme has collected nationally representative data on influenza circulation for nearly 25 years and is a key contributor of influenza viruses for determining the components of the Southern Hemisphere influenza vaccine.
In collaboration with NCIRD ID, South Africa has expanded their influenza surveillance activities to include respiratory hospitalizations in five of nine provinces following the 2009 pandemic.
This surveillance platform has allowed them to better understand some risk factors for severe disease; however, it has not generated significant data on the burden of influenza or influenza vaccine effectiveness in some groups targeted for vaccination, particularly pregnant women and their young infants.
This new cooperative agreement will allow NCIRD ID to expand collaborations with NICD to look at these and other at risk populations.
South Africa’s Viral Watch Programme has collected nationally representative data on influenza circulation for nearly 25 years and is a key contributor of influenza viruses for determining the components of the Southern Hemisphere influenza vaccine.
In collaboration with NCIRD ID, South Africa has expanded their influenza surveillance activities to include respiratory hospitalizations in five of nine provinces following the 2009 pandemic.
This surveillance platform has allowed them to better understand some risk factors for severe disease; however, it has not generated significant data on the burden of influenza or influenza vaccine effectiveness in some groups targeted for vaccination, particularly pregnant women and their young infants.
This new cooperative agreement will allow NCIRD ID to expand collaborations with NICD to look at these and other at risk populations.
Related Programs
Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Rel
Department of Health and Human ServicesCenters for Disease Control and Prevention_Investigations and Technical Assistance
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention
Estimated Funding: $14,000,000
Office: Centers for Disease Control and Prevention
Estimated Funding: $14,000,000
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
Additional Information of Eligibility:
Additional Information on Eligibility Single-Source Competition National Institute for Communicable Diseases, Republic of South Africa
Full Opportunity Web Address:
Contact:
Deborah Loveyshft6@cdc.gov
Agency Email Description:
Grants Policy
Agency Email:
hft6@cdc.gov
Date Posted:
2015-11-09
Application Due Date:
2016-01-15
Archive Date:
2016-02-14
Social Entrepreneurship
Spotlight
Rwanda as Social Entrepreneur Fund Beneficiary
The Republic of Rwanda has been picked as one of the six African countries as beneficiaries for a new fellowship fund program designed at supporting social entrepreneurs in tackling issues on food security.
Learn How to Identify and Avoid Grant Scams
